Essix Biosciences Acquired 70 Lakh Warrants in Ind-Swift Laboratories
Ind-Swift Laboratories Ltd 路 Others (Uncategorized) 路 21 Sept 2026, 11:41 pm
Essix Biosciences Acquired 70 Lakh Warrants in Ind-Swift Laboratories Promoter entity Essix Biosciences acquired 70,00,000 fully convertible warrants in Ind-Swift Laboratories on a preferential basis for cash on 17th Sep'26, representing 7.45% of diluted capital. Post-transaction, Essix Biosciences and persons acting in concert hold 3,73,34,278 equity shares (42.93% voting capital) and 70,00,000 warrants, raising their combined diluted stake from 43.06% to 47.18%. Following the preferential allotment and an ESOP exercise of 2,50,000 shares, the company's total diluted share capital stands at Rs. 93.96 crore, comprising 9,39,61,558 equity shares.
Original exchange filing (PDF)
More announcements from Ind-Swift Laboratories Ltd
- Please find enclosed transcript for earnings call held on November 04, 2026. 路 10 Nov 2026
- Audio recording of earning conference call held on 04.11.2026 on un-audited financial results for the quarter ended 30.09.2026. 路 05 Nov 2026
- Please find enclosed investor presentation on un-audited financial results for the quarter ended September 30, 2026 路 04 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 in respect of receipt of funds raised through preferential issue of 70,00,000 Fully Convertible Warrants 路 03 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 in respect of funds raised through Preferential Issue 2.6 Cr Fully Convertible Warrants 路 03 Nov 2026
- Please find enclosed Schedule of Analyst / Investor Meet which will be held on Wednesday, November 04, 2026, at 04.00 P.M. IST in respect of financial results of the Company for the quarter .... 路 04 Nov 2026
- Press Release in respect of Unaudited Financial Results (Standalone & Consolidated) for the second quarter and half year ended September 30, 2026 路 30 Oct 2026
- Please refer attached pdf 路 30 Oct 2026
